___

• Pfelger L, Tappeiner J. Zur kenntnis der systemisierten endothe-. liomatose der cutanen blutgefasse [Germany]. Hautarzt 1959;10:359-63.
• Petersdorf RB, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 1961;40:1-30.
• Baicus C, Ionescu R, Tanasescu C. Does this patient have cancer? The assessment of age, anemia, and erythrocyte sedimentation rate in cancer as a cause of weight loss. A retrospective study based on a secondary care university hospital in Romania. Eur J Intern Med Volume 2006;17(1):28–31.
• Bleeker-Rovers C, Kleijn E, Corstens F, Meer J, Oyen W. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation . Eur J Nucl Med Mol Imaging 2004:31(1):29-37
• Zhuang H, Pourdehnad M, Lambright ES et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7.
• Principles of Ambulatory Medicine; barker, Burton and Zieve’s; 7th edition.
• Didier S, Mas JL, Fallet-Bianco C, et al. Intravascular lymphomatosis (neoplastic angioendotheliosis) of the central nervous system: case report and literature review. J Neuro Oncol 1991:11:171-80.
• Wrotnowski U, Mills SE, Cooper PH. Malignant angioendotheliomatosis. An angiotropic lymphoma? Am J Clin Pathol 1985;83:244-8
• Ponzoni M, Ferren AJM. Intravascular lymphoma: a neoplasm of homeless lymphocytes? Hemato Oncol 2006; 24:105-12
• Beal MF, Fisher CM: Neoplastic angioendotheliosis. J Neurol Sci 1982;53:359-75.
• Demirer T, Dail D, Aboulafia D. Four varied cases of Intravscular lymphomatosis and a Literature review. Cancer 1994;73:1738-45
• Ferreri AJ, Campo E, Seymour JF et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in series of 38 cases, with special emphasis on the ‘cutaneous variant’. Cr J hematology 2004;127(2):173-83
• Kuvliev E, Glamour T, Shekar R, West B. Angiotropic Large Cell Lymphoma Presenting as Fever of Unknown Origin. American Journal of the Medical Sciences. 317(4):266-268, April 1999.
• Carrol TJ, Schelper RL, Goeken JA, Kemp JD. Neoplastic angioendotheliomatosis: Immunopathologic and morphologic evidence of malignant intravascular lymphomatosis. Am J Clin Pathol 1986; 85:169-75
• Askarian F, Xu D; Adrenal enlargement and insufficiency: a common presentation of intravascular large B-cell lymphoma. Am J Hematol. 2006 Jun;81(6):411-3.
• Watabe R, Shibata K, Hirase N, Kodera T, Muta K, Nishimura J, Nawata H. Angiotropic B-cell lymphoma with hemophagocytic syndrome associated with syndrome of inappropriate secretion of antidiuretic hormone. Ann Hematol. 2000 Oct;79(10):581-4.
• Shanks JH, Harris M, Howat AJ, Freemont AJ. Angiotropic lymphoma with endocrine involvement. Histopathology. 1997 Aug;31(2):161-6.
• Zhuang H, Pourdehnad M, Lambright ES et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7.
• MacManus MP, Hicks RJ, Matthews JP et al. High rate of detection of unsuspected distant metastases by PET in apparent stage III non-small cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:287-93.
• Odawara J, Asada N, Aoki T, Yamakura M, Takeuchi M, Ohuchi T, et al. 18F-Fluorodeoxyglucose positron emission tomography for evaluation of intravascular large B-cell lymphoma. Br J Haematol. 2007;136:684.